Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use

Inventors: Georg Schlechtingen (Cologne, DE); Hans-Joachim Knölker (Dresden, DE); Tim Friedrichson (Dresden, DE); Gary Jennings (Dresden, DE); Tobias Braxmeier (Kuppenheim, DE)

Assignee: GRI BIO, INC.

C07C309/14 A61K31/205

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 9,751,834
App. No.: 14/403,168
Granted: Sep 5, 2017
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The present invention relates to oxygenated amino or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives, in particular the compounds of formula 1, 2, 3, 4, 5 or 6, and their medical use, including their use in the treatment, prevention or amelioration of an inflammatory, autoimmune and/or allergic disorder, or a proliferative, neoplastic or dysplastic disease or disorder.

Claims (3)

1. A compound of the following formula 1a:

or a pharmaceutically acceptable salt or solvate thereof.

2. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable excipient.

Assignments (4)

SECURITY INTEREST Recorded Dec 15, 2022

From: GRI BIO, INC.

To: ALTIUM GROWTH FUND, LP

Reel/Frame 062108/0599 →

SECURITY INTEREST Recorded Nov 2, 2018

From: GRI BIO, INC.

To: TEP BIOTECH, LLC